Axonics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-6.09	-59.7	-80.07	-54.92	-79.94	-32.48	-18.06	-17.4
Depreciation & Amortization	12.49	11.72	9.13	1.74	1.19	0.95	0.73	0.63
Share-Based Compensation	44.54	32.02	25.16	15.1	8.72	0.61	0.46	0.32
Other Operating Activities	-52.95	19.15	-1.53	-45.66	-13.43	-0.44	-1.3	-0.88
Operating Cash Flow	-2.02	3.19	-47.31	-83.74	-83.45	-31.37	-18.18	-17.34
Capital Expenditures	-3.55	-2.22	-2.26	-2.94	-1.34	-1.23	-1.04	-0.29
Acquisitions	0	0	-140.74	0	0	0	0	0
Change in Investments	-113.35	-118.13	0	12.59	46.63	-58.82	0	0
Investing Cash Flow	-116.9	-120.35	-143	9.65	45.29	-60.05	-1.04	-0.29
Share Issuance / Repurchase	4.25	133.97	196.74	144.19	110.96	125.59	0.02	0
Debt Issued / Paid	0	0	-26.22	0	0	19.86	0	0
Other Financing Activities	-7.63	-	-	-	-	19.9	34.79	1.63
Financing Cash Flow	-3.38	133.97	170.51	144.19	110.96	165.34	34.82	1.63
Exchange Rate Effect	0.98	1.16	-0.51	-0	-0.01	-0.01	0.59	-0
Net Cash Flow	-121.32	17.97	-20.3	70.1	72.78	73.91	16.19	-16
Free Cash Flow	-5.57	0.97	-49.57	-86.68	-84.79	-32.6	-19.21	-17.63
Free Cash Flow Margin	-1.52%	0.35%	-27.49%	-77.72%	-613.55%	-4610.75%	-15010.94%	-
Free Cash Flow Per Share	-0.11	0.02	-1.15	-2.34	-2.97	-4.66	-7.49	-7.62

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).